Latest News

Earlier this month, Personalis announced clinical data from the 2026 ASCO meeting showing its NeXT Personal assay can detect minimal residual disease at ultra-low levels across six solid tumor types, with strong correlations to relapse and progression risk in colorectal, lung, ovarian, endometrial, melanoma, and renal cancers. Shortly afterward, the company received CE Mark Class A approval for its EDTA and cfDNA Blood Collection Kits, opening the door for broader use of its MRD ecosystem in...

The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market conditions, there remains potential for investors willing to explore smaller or newer companies known as penny stocks. Although the term may seem outdated, these stocks can offer unique opportunities when backed by strong financials and sound fundamentals, providing a chance for growth at lower...

The United Kingdom's FTSE 100 index has recently faced downward pressure, influenced by weak trade data from China and a sluggish recovery in its economy, impacting companies with strong ties to Chinese markets. Amidst these challenges, identifying undervalued stocks can be crucial for investors seeking potential opportunities; such stocks may offer significant growth potential if their intrinsic value is indeed higher than current market prices.

In recent days, Alpha Metallurgical Resources benefited from a sector-wide upswing in coking coal producers, as improving sentiment toward metallurgical coal lifted the company alongside peers such as Warrior Met Coal and Ramaco Resources. At the same time, insider purchases totaling about US$4.40 million and indications that the shares may be trading above intrinsic value add an interesting contrast between internal confidence and external valuation assessments. We’ll now examine how this...

As the United Kingdom's FTSE 100 index faces challenges from weak trade data out of China, impacting sectors like mining and fund management, investors are increasingly looking towards lesser-known opportunities within the market. In this environment, identifying small-cap stocks with strong fundamentals and growth potential becomes crucial for those seeking to navigate the current economic landscape effectively.

As the FTSE 100 and FTSE 250 indices experience declines due to weak trade data from China, investors in the UK market are facing a challenging environment marked by global economic uncertainties. In such conditions, dividend stocks can offer a measure of stability and income, making them an attractive option for those looking to navigate volatile markets.

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

As you might know, Figeac Aero Société Anonyme ( EPA:FGA ) recently reported its full-year numbers. It was an okay...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

In recent months, Corvus Pharmaceuticals reported encouraging Phase 1 results for its oral ITK inhibitor soquelitinib in atopic dermatitis, showing early efficacy signals alongside a clean safety profile and extending its cash runway into the second quarter of 2028. These developments, coupled with upbeat coverage from investment commentators highlighting soquelitinib’s potential to compete in immunology and attract larger partners, have drawn fresh attention to Corvus’s pipeline and funding...

Saputo Inc. has reported full-year results for the period ended March 31, 2026, with sales of CA$17,551 million and net income of CA$672 million, and its board approved a CA$0.20 per share dividend payable on June 25, 2026, to shareholders of record on June 16, 2026. The shift from a net loss in the prior year to positive earnings per share across both basic and diluted measures highlights a significant turnaround in the company’s profitability profile. Next, we’ll examine how Saputo’s...

In early June 2026, Asana, Inc. launched an “operating system for human-agent teams,” centered on its Agentic Work Management suite, AI Teammates, Asana Dash, and new industry-specific agents that coordinate humans and AI across tools like Slack, Gmail, and major enterprise systems. By tightly integrating its AI agents with StackAI to orchestrate complex workflows across CRMs, ERPs, and collaboration platforms, Asana is positioning its platform as a central hub for AI-powered work execution...

Recent deal activity at Everest Medicines (SEHK:1952), including the LNZ100 ophthalmology license in Greater China and the Sumecigrel cardiovascular collaboration, has put the stock back in focus for investors evaluating its business development approach. See our latest analysis for Everest Medicines. These licensing deals have arrived during a weak patch for the stock, with the share price down 26.91% year to date and the 1-year total shareholder return falling 45.09%. However, the 3-year...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

As European markets navigate a complex landscape marked by the ECB's recent interest rate hike and ongoing geopolitical tensions, investors are closely monitoring small-cap stocks for potential opportunities. With the pan-European STOXX Europe 600 Index showing gains and hopes rising for a peace agreement in the Middle East, understanding what makes a good stock—such as strong fundamentals and favorable insider activity—can be crucial in identifying promising investments in this dynamic...

As European markets navigate a mixed landscape amid geopolitical tensions and recent interest rate hikes by the ECB, investors are keenly observing growth opportunities that can withstand economic uncertainties. In this context, companies with high insider ownership often signal confidence in their long-term prospects, making them attractive for those seeking growth potential.

Fresh funding supports upcoming drilling, resource growth, and multiple exploration catalysts for Upside Gold's Kena project.

European markets have shown mixed performance recently, with the pan-European STOXX Europe 600 Index rising by 1.69% amid geopolitical tensions and the European Central Bank's decision to raise interest rates for the first time since 2023. Despite these broader market fluctuations, penny stocks remain a compelling area of interest for investors seeking growth opportunities at lower price points. Although considered a somewhat outdated term, penny stocks often represent smaller or newer...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

As European markets navigate mixed signals from the European Central Bank's interest rate hike and geopolitical tensions, the pan-European STOXX Europe 600 Index has shown resilience, closing up 1.69% recently. Amid this backdrop, investors are keenly exploring opportunities in small-cap stocks that may offer potential growth despite broader economic uncertainties. Identifying promising stocks often involves looking for companies with strong fundamentals and innovative approaches that can...

As European markets navigate a landscape marked by the European Central Bank's recent interest rate hike and ongoing geopolitical tensions, investors are keenly observing how these factors influence economic growth and inflation across the region. Against this backdrop, dividend stocks remain an attractive option for those seeking steady income streams, particularly as they can offer a buffer against market volatility and inflationary pressures.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Shareholders of DO & CO Aktiengesellschaft ( VIE:DOC ) will be pleased this week, given that the stock price is up 11...

Mitsubishi (TSE:8058) stock has been active recently, with the share price at ¥4,683 and returns mixed, up 1.7% over the past day but down 20% over the past month. See our latest analysis for Mitsubishi. The recent pullback, including a 20% decline in the 30 day share price return and softer 90 day performance, contrasts with a stronger backdrop where the year to date share price return is up 28.2% and the 1 year total shareholder return is 68.73%. This suggests momentum has cooled after a...